On November 4, Regen Gene (688217.SH) announced that in October 2024, the company did not repurchase any shares. As of October 31, 2024, the company had repurchased a total of 669,621 shares through the Shanghai Stock Exchange trading system via centralized bidding trading method, accounting for 1.20% of the total share capital of 55,855,896 shares. The highest repurchase price was 27.67 yuan/share, the lowest price was 22.37 yuan/share, and the total amount paid was RMB 17,021,747.99 (excluding stamp duty, trading commission, and other trading fees).
睿昂基因(688217.SH)：10月公司未回购股份
Raygene (688217.SH): The company did not repurchase shares in October.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated